UK trial assessing AZ’ AZD1775 in head and neck cancer
A clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with…
A clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with…
ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in…
AstraZeneca has signed a deal with US group G1 Therapeutics to test the potential of a new combination therapy for…
WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today…
Bayer and Nektar Therapeutics’ experimental inhaled antibiotic has failed to hit key targets assessing its effect on survival in patients…
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced that GSK, a world leader in respiratory,…
When tracking clinical trial activity across the world, GlobalData, a leading data and analytics company, identified 5,273 industry monoclonal antibodies…
Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high…
SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient to a Phase…